Carmine Circelli is Director of Direct Life Science Investments at British Patient Capital. British Patient Capital is a commercial subsidiary of the British Business Bank, the UK government’s economic development bank. British Patient Capital’s mission is to enable long-term investment in innovative UK companies led by ambitious entrepreneurs who want to build successful, world-class businesses. British Patient Capital’s programmes target the later stage equity finance gap faced by innovative, R&D-intensive UK companies with cutting edge technologies.
Carmine has more than seven years of investment experience in the life science and software sectors from early to late stage. He also has experience in drug development, scientific sales and patent commercialisation.
Carmine holds a BSc in Pharmacology and a PhD in Cardiovascular Medicine from the University of Manchester.